Back to Search

DEEVA BHATT

Pediatric Dentistry

NPI: 1790278166Individual

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Pediatric DentistryPrimary

Dentist — Pediatric Dentistry

Code: 1223P0221X

11847(NC)

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes Medications

NCT01107886COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (15)

Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial.
PMID 33832610·J Am Coll Cardiol·2021
8-other
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
PMID 31474116·Circulation·2019
4-observational
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.
PMID 31362530·Circulation·2019
3-trial
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.
PMID 29214305·JAMA Cardiol·2018
4-observational
DPP4 inhibitors and cardiovascular outcomes: safety on heart failure.
PMID 28417296·Heart Fail Rev·2017
6-review
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial.
PMID 27797925·Diabetes Care·2017
4-observational
Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial.
PMID 27681000·JAMA Cardiol·2016
8-other
Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
PMID 26524706·Am J Med·2016
3-trial
Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial.
PMID 26358285·Diabetes Care·2015
4-observational
Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial.
PMID 25758769·Diabetes Care·2015
4-observational
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial.
PMID 25552421·Diabetes Care·2015
4-observational
Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.
PMID 25189213·Circulation·2014
2-rct
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
PMID 23992601·N Engl J Med·2013
3-trial
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial.
PMID 23564755·Diabetes Metab Res Rev·2013
4-observational
The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study.
PMID 22093196·Am Heart J·2011
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 3 locations total

Address
1395 CENTER DR
GAINESVILLE, FL 32610

Locations (3)

Practice Location

1395 CENTER DR, GAINESVILLE, FL
(352) 273-5800

Practice Location

11990 S Aviary Dr, Hollywood, FL
(954) 292-3722

Practice Location

140 MAHALEY AVE STE B, SALISBURY, NC
(704) 637-5506

Quick Facts

NPI
1790278166
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
2
Locations
3
Clinical Trials
1
Publications
15

Are you this provider?

Claim Your Profile